Imprimis Pharmaceuticals Inc. (IMMY) Financials Nov 14, 2014, 3:59 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Imprimis Pharmaceuticals Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 0 0 0 100,000 10,000
Cost of Goods Sold (COGS) incl. D&A 1,056 1,056 338 2,944 5,659
COGS excluding D&A 0 0 0 0 0
Depreciation & Amortization Expense 1,056 1,056 338 2,944 5,659
Depreciation 1,056 1,056 338 2,944 5,659
Amortization of Intangibles 0 0 0 0 0
Gross Income (1,056) (1,056) (338) 97,056 4,341
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 4.56M 2.5M 938,890 4.27M 7.69M
Research & Development 2.97M 194,588 111,554 1.3M 1.62M
Other SG&A 1.6M 2.31M 827,336 2.98M 6.08M
Other Operating Expense 0 0 0 1,600 0
Unusual Expense 436 (26,299) (60,292) 1.2M 0
EBIT after Unusual Expense (436) 26,299 60,292 (1.2M) 0
Non Operating Income/Expense 0 0 0 0 0
Non-Operating Interest Income 10,440 512 - 15,410 43,755
Equity in Affiliates (Pretax) 0 0 0 - 0
Interest Expense 0 55,479 75,000 24,658 0
Gross Interest Expense 0 55,479 75,000 24,658 0
Interest Capitalized 0 0 0 0 0
Pretax Income (4.55M) (2.53M) (953,936) (5.38M) (7.64M)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 0 - -
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 0 0 0 - -
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 0 0 0 - -
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (4.55M) (2.53M) (953,936) (5.38M) (7.64M)
Minority Interest Expense 0 0 0 0 0
Net Income (4.55M) (2.53M) (953,936) (5.38M) (7.64M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (4.55M) (2.53M) (953,936) (5.38M) (7.64M)
Preferred Dividends 0 0 100,000 200,000 0
Net Income Available to Common (4.55M) (2.53M) (1.05M) (5.58M) (7.64M)
EPS (Basic) (11.60) (6.40) (2.80) (1.24) (0.88)
Basic Shares Outstanding 390,325 394,631 397,803 4.49M 8.66M
EPS (Diluted) (11.60) (6.40) (2.80) (1.24) (0.88)
Diluted Shares Outstanding 390,325 394,631 397,803 4.49M 8.66M
EBITDA (4.56M) (2.5M) (938,890) (4.18M) (7.68M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Imprimis Pharmaceuticals Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 0 0 0 100,000 10,000
Cost of Goods Sold (COGS) incl. D&A 1,056 1,056 338 2,944 5,659
COGS excluding D&A 0 0 0 0 0
Depreciation & Amortization Expense 1,056 1,056 338 2,944 5,659
Depreciation 1,056 1,056 338 2,944 5,659
Amortization of Intangibles 0 0 0 0 0
Gross Income (1,056) (1,056) (338) 97,056 4,341
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 4.56M 2.5M 938,890 4.27M 7.69M
Research & Development 2.97M 194,588 111,554 1.3M 1.62M
Other SG&A 1.6M 2.31M 827,336 2.98M 6.08M
Other Operating Expense 0 0 0 1,600 0
Unusual Expense 436 (26,299) (60,292) 1.2M 0
EBIT after Unusual Expense (436) 26,299 60,292 (1.2M) 0
Non Operating Income/Expense 0 0 0 0 0
Non-Operating Interest Income 10,440 512 - 15,410 43,755
Equity in Affiliates (Pretax) 0 0 0 - 0
Interest Expense 0 55,479 75,000 24,658 0
Gross Interest Expense 0 55,479 75,000 24,658 0
Interest Capitalized 0 0 0 0 0
Pretax Income (4.55M) (2.53M) (953,936) (5.38M) (7.64M)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 0 - -
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 0 0 0 - -
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 0 0 0 - -
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (4.55M) (2.53M) (953,936) (5.38M) (7.64M)
Minority Interest Expense 0 0 0 0 0
Net Income (4.55M) (2.53M) (953,936) (5.38M) (7.64M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (4.55M) (2.53M) (953,936) (5.38M) (7.64M)
Preferred Dividends 0 0 100,000 200,000 0
Net Income Available to Common (4.55M) (2.53M) (1.05M) (5.58M) (7.64M)
EPS (Basic) (11.60) (6.40) (2.80) (1.24) (0.88)
Basic Shares Outstanding 390,325 394,631 397,803 4.49M 8.66M
EPS (Diluted) (11.60) (6.40) (2.80) (1.24) (0.88)
Diluted Shares Outstanding 390,325 394,631 397,803 4.49M 8.66M
EBITDA (4.56M) (2.5M) (938,890) (4.18M) (7.68M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
